Here's RUT 30-day, 1 hour to show that we likely haven't hit the e to end the diagonal yet.
Very soon it will emerge Moderna MRNA was a company just like NKLA
— emini tic (@TicTocTick) August 10, 2021
It will trade 66 dollar (now 480)
I'm thinking $115, and if so, then very possibly $125. Not a scalp though.Ranger222 said:
AMD out of hourly decline....could scalp to 110
I mean, MRNA actually has a real product that is very much in demandFJ43 said:
Time to sell.Very soon it will emerge Moderna MRNA was a company just like NKLA
— emini tic (@TicTocTick) August 10, 2021
It will trade 66 dollar (now 480)
H-town ag said:
WWR with some volume and push to 4.34.
CrazyRichAggie said:H-town ag said:
WWR with some volume and push to 4.34.
Being out our girl for some good luck.
I heard they never got through a Phase 3 on.. anything prior to the emergency use FDA approval. Is that true?Ranger222 said:
Moderna was a crappy company in the biotech world prior to COVID. Already considered overvalued in Jan 2020. I'm pretty sure they were heavily shorted prior to any of the vaccine stuff. There was a feeling that the prior administration was giving them a lifeline by making them one of the heavy COVID vaccine players. Credit to them they delivered, but I'm sure those pre-Jan2020 feelings haven't gone away among a group of investors. Maybe they are right, maybe they turn into the next TSLAQ group. We shall see
Correct. Even the COVID vax looks like it never even got through Phase 2 prior to emergency approval.Ranger222 said:
I may be incorrect but I'm pretty sure they had no FDA approved product (and technically still don't) prior to the COVID vaccine. Everything from them was still in development and they IPOd with billions in valuation for a company that didn't have a product
mazag08 said:I'm thinking $115, and if so, then very possibly $125. Not a scalp though.Ranger222 said:
AMD out of hourly decline....could scalp to 110
take some off here$30,000 Millionaire said:
move $ZEV stops to B/E
Well that makes me want to run out and get the jab.mazag08 said:Correct. Even the COVID vax looks like it never even got through Phase 2 prior to emergency approval.Ranger222 said:
I may be incorrect but I'm pretty sure they had no FDA approved product (and technically still don't) prior to the COVID vaccine. Everything from them was still in development and they IPOd with billions in valuation for a company that didn't have a product
wowjimmo said:
just stumbled on this chart
NXRP
drug co. w/ new covid treatment; pending approval; EUA given for Georgia
But it was the recent volume spikes that caught my eye. yuge vol
Looks to have hit a low at $104.36 after it's huge run. Possibly gearing up for another mini run here. I'm looking for confirmation above $108.5. If we get it, I think the runway is clear for $110 first, then $115ish, with $125 as a very real possibility.Talon2DSO said:mazag08 said:I'm thinking $115, and if so, then very possibly $125. Not a scalp though.Ranger222 said:
AMD out of hourly decline....could scalp to 110
What's the play here?
I would take profits today before close on the 8/13. Theta will nuke any value.Talon2DSO said:
I have the following AMD
8/27 $105c
8/13 $115c
10/15 $125c
I'm up nicely on the 8/27 and 10/15 calls. Just a hair in the green for the 8/13